Chordate Medical Holding AB
Chordate Medical Holding AB (publ), a medical technology company, engages in the development of products and solutions for neurostimulation treatment in Sweden. It offers Ozilia, a neuromodulation and medication-free treatment technology for chronic migraine and chronic rhinitis. The company was founded in 2005 and is based in Kista, Sweden.
Chordate Medical Holding AB (CMH) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of June 2025: -0.514x
Based on the latest financial reports, Chordate Medical Holding AB (CMH) has a cash flow conversion efficiency ratio of -0.514x as of June 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Skr-7.14 Million) by net assets (Skr13.90 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Chordate Medical Holding AB - Cash Flow Conversion Efficiency Trend (2015–2024)
This chart illustrates how Chordate Medical Holding AB's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Chordate Medical Holding AB Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Chordate Medical Holding AB ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
FIRST RESOURCES (5F1.SG)
STU:5F1
|
0.031x |
|
Giga-tronics Inc
PINK:GIGA
|
-0.017x |
|
PARAGON - Dusseldorf Stock Exchang
DU:PGN
|
-0.447x |
|
BELSHIPS ASA NK 2
F:NS6
|
N/A |
|
AUTOMOB PARTICIPACOES S.A.
SA:AMOB3
|
0.002x |
|
Global PVQ SE
PINK:QCLSF
|
3.126x |
|
Kore Potash Plc
LSE:KP2
|
0.000x |
|
GREAT EAGLE
MU:GHK
|
N/A |
Annual Cash Flow Conversion Efficiency for Chordate Medical Holding AB (2015–2024)
The table below shows the annual cash flow conversion efficiency of Chordate Medical Holding AB from 2015 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | Skr9.20 Million | Skr-24.41 Million | -2.654x | -46.89% |
| 2023-12-31 | Skr15.09 Million | Skr-27.26 Million | -1.807x | +19.89% |
| 2022-12-31 | Skr11.07 Million | Skr-24.98 Million | -2.256x | -332.08% |
| 2021-12-31 | Skr38.95 Million | Skr-20.34 Million | -0.522x | +23.19% |
| 2020-12-31 | Skr25.64 Million | Skr-17.43 Million | -0.680x | +55.95% |
| 2019-12-31 | Skr10.98 Million | Skr-16.95 Million | -1.543x | +8.48% |
| 2018-12-31 | Skr11.26 Million | Skr-18.99 Million | -1.686x | -61.95% |
| 2017-12-31 | Skr18.24 Million | Skr-18.99 Million | -1.041x | -219.15% |
| 2016-12-31 | Skr29.55 Million | Skr-9.64 Million | -0.326x | +6.19% |
| 2015-12-31 | Skr35.72 Million | Skr-12.42 Million | -0.348x | -- |